A detailed history of Moody Aldrich Partners LLC transactions in Vaxcyte, Inc. stock. As of the latest transaction made, Moody Aldrich Partners LLC holds 54,169 shares of PCVX stock, worth $5.75 Million. This represents 1.23% of its overall portfolio holdings.

Number of Shares
54,169
Previous 100,286 45.99%
Holding current value
$5.75 Million
Previous $7.57 Million 18.33%
% of portfolio
1.23%
Previous 1.6%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 22, 2024

SELL
$70.52 - $117.12 $3.25 Million - $5.4 Million
-46,117 Reduced 45.99%
54,169 $6.18 Million
Q2 2024

Jul 23, 2024

SELL
$60.06 - $78.77 $1.1 Million - $1.44 Million
-18,316 Reduced 15.44%
100,286 $7.57 Million
Q1 2024

Apr 29, 2024

SELL
$59.79 - $81.05 $1.75 Million - $2.38 Million
-29,325 Reduced 19.82%
118,602 $8.1 Million
Q4 2023

Jan 25, 2024

BUY
$45.35 - $63.41 $351,779 - $491,871
7,757 Added 5.53%
147,927 $9.29 Million
Q3 2023

Nov 07, 2023

BUY
$46.0 - $53.1 $5.31 Million - $6.13 Million
115,505 Added 468.3%
140,170 $7.15 Million
Q2 2023

Jul 28, 2023

BUY
$34.66 - $54.07 $854,888 - $1.33 Million
24,665 New
24,665 $1.23 Million

Others Institutions Holding PCVX

About Vaxcyte, Inc.


  • Ticker PCVX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,315,100
  • Market Cap $6.3B
  • Description
  • Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine that is in Phase 1/2 clinical trials to treat invasive pneumococcal disease and pneumonia. The company a...
More about PCVX
Track This Portfolio

Track Moody Aldrich Partners LLC Portfolio

Follow Moody Aldrich Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Moody Aldrich Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Moody Aldrich Partners LLC with notifications on news.